◆ 会议时间：2025年11月6-7日
◆ 会议地点：美国 纽约

◆ 会议简介：

2025年第17届骨髓增殖性肿瘤国际大会将于2025年11月6-7日在美国纽约举行，会议将为来自世界各地的与会者提供及时、相关和有意义的有关骨髓增殖性肿瘤诊断和治疗方面的信息。未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

17th International Congress on Myeloproliferative Neoplasms (MPN Congress) 2025

Date:
November 6-7, 2025

Venue:
New York Marriott at the Brooklyn Bridge
New York, USA

摘要征集-Abstract Submission：

Submission Deadline: September 22, 2025

Participants interested in presenting data should submit abstracts by email to abstracts@mpncongress.com on or before September 22, 2025

Dear Colleagues,

We are delighted to invite you to attend the 17th International Congress on Myeloproliferative Neoplasms convening on November 6-7, 2025 at the New York Marriott-Brooklyn Bridge in Brooklyn, New York. This event, founded in 2001, and now held annually, serves as a cornerstone for advancing education about the myeloproliferative neoplasms (MPN).

The two-day program features world-renowned faculty and offers CME credits for physicians and CE credits for nurse practitioners, physician assistants, and nurses. With an emphasis on robust faculty interaction and active audience engagement, the MPN Congress features an interactive format with a Q&A session following each speaker’s presentation. In addition, based on positive feedback from the last Congress, we will continue both the debate session and the nurse-led session.

Participants can also enjoy numerous networking opportunities and one-on-one discussions with the faculty and other attendees, promoting collaboration and knowledge-sharing among professionals in the MPN field.

The MPN Congress encourages abstract submissions (sanctioned by the ASH), offering an excellent platform for fellows, faculty and others to display their clinical or scientific research through a poster forum during the Congress. Awards will be presented for outstanding abstracts, and the abstract selected as “best” will be highlighted with an oral presentation during the general session.

There is a time for every season.  At this year’s Congress, Dr. Jerry Spivak, who has Co-Chaired the Congress since its founding in 2001, will become Chair, and Dr. Richard Silver will become Chair Emeritus.  We are also pleased to announce that Dr. Naveen Pemmaraju and Dr. John Mascarenhas, who have served on the Congress Program Committee, will become Co-Chairs.

We hope you will join us for what promises to be an engaging educational event.

Warm regards,

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。